Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yngvill Hovde Bragnes"'
Autor:
Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Guro Løvik Goll, Marthe Kirkesæther Brun, Øystein Sandanger, Kristin Hammersbøen Bjørlykke, Joseph Sexton, Inge Christoffer Olsen, Johanna Elin Gehin, David John Warren, Rolf Anton Klaasen, Geir Noraberg, Trude Jannecke Bruun, Christian Kvikne Dotterud, Maud Kristine Aga Ljoså, Anne Julsrud Haugen, Rune Johan Njålla, Camilla Zettel, Carl Magnus Ystrøm, Yngvill Hovde Bragnes, Svanaug Skorpe, Turid Thune, Kathrine Aglen Seeberg, Brigitte Michelsen, Ingrid Marianne Blomgren, Eldri Kveine Strand, Pawel Mielnik, Roald Torp, Cato Mørk, Tore K. Kvien, Jørgen Jahnsen, Nils Bolstad, Espen A. Haavardsholm
Publikováno v:
JAMA
IMPORTANCE: Proactive therapeutic drug monitoring (TDM), consisting of individualized treatment based on scheduled assessments of serum drug levels, has been proposed as an alternative to standard therapy to optimize efficacy and safety of infliximab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f19e319169617671a2db100d68ab77ac
https://europepmc.org/articles/PMC8693274/
https://europepmc.org/articles/PMC8693274/
Autor:
Nils Bolstad, Svanaug Skorpe, Yngvill Hovde Bragnes, Øystein Sandanger, Anne Julsrud Haugen, Roald Torp, Lars Normann Karlsen, Silje W Syversen, G. L. Goll, Ingrid M. Blomgren, David J. Warren, Camilla Zettel, Inge C. Olsen, Turid Thune, Christian Kvikne Dotterud, Brigitte Michelsen, Jørgen Jahnsen, Rune Johan Njålla, Geir Noraberg, K. K. Jørgensen, Pawel Mielnik, Carl Magnus Ystrøm, Kathrine A. Seeberg, J. E. Gehin, Joseph O. Sexton, Tore K Kvien, C. Mørk, Maud Kristine Aga Ljoså, Rolf Anton Klaasen, Trude Jannecke Bruun, Marthe Kirkesæther Brun, Espen A Haavardsholm, E. K. Strand
Publikováno v:
Journal of the American Medical Association (JAMA)
Importance Proactive therapeutic drug monitoring (TDM), defined as individualized drug dosing based on scheduled monitoring of serum drug levels, has been proposed as an alternative to standard therapy to maximize efficacy and safety of infliximab an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7427e8aee61a86b9681517c460490d0
https://hdl.handle.net/11250/3048675
https://hdl.handle.net/11250/3048675